Business
Kali-Extracts, Inc. Announces Cannabis Biotech Inventor Frederick Ferri as New CEO to Lead Company Into $28 Billion Medical Cannabis Market
Kali-Extracts, Inc. Announces Cannabis Biotech Inventor Frederick Ferri as New CEO to Lead Company Into $28 Billion Medical Cannabis Market.
About this update from Kali Inc
[{"type":"text","content":"\n\n\n\nKali-Extracts, Inc. Announces Cannabis Biotech Inventor Frederick Ferri as New CEO to Lead Company Into $28 Billion Medical Cannabis Market\n\n\n\n\n\nKali-Extracts, Inc. Announces Cannabis Biotech Inventor Frederick Ferri as New CEO to Lead Company Into $28 Billion Medical Cannabis Market\nPR Newswire\nDALLAS, December 19, 2018\n\n\n\nDALLAS, December 19, 2018 /PRNewswire/ --\n\nKali, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (\"KALY\") today announced Frederick Ferri as the company's new CEO. Mr. Ferri is the inventor of a patented cannabis extraction process. On November 15th, 2018, KALY acquired Mr. Ferri's company NCM Biotech to include the patented cannabis extraction process he invented. The acquisition includes the extensive preclinical trial research conducted with cannabis extracts from the patented cannabis extraction process. The NCM Biotech Medical Advisory Team includes John N. Gaitanis, MD., Director of Child Neurology at Tufts Medical Center/Floating Hospital for Children; Lloyd R. Saberski, M.D., Associate Professor of Anesthesiology and Chronic Pain Management, Yale University, and John McMichael, Ph.D., President & CEO Beech Tree Labs. \n\n\"My first act as the new CEO of Kali-Extracts is to announce the new Kali Cannabis Therapies subsidiary,\" said Mr. Ferri. \"I am enthusiastic about the nutritional and wellness products such as Hemp4mula and EVERx that are already generating revenue for Kali-Extracts either through internal product sales or through the licensing of our technology.  The extraordinary and yet unrealized value of Kali-Extracts is in the cannabis biotechnology intellectual properties that came with the NCM Biotech acquisition.  Kali-extracts now has years of research and studies surrounding a multitude of applications of our proprietary cannabis extracts.  In a separate release later today, the company will publish a formal announcement of the Kali Cannabis Therapies subsidiary to include specific information on preclinical research studies on one particular application of our proprietary cannabis extracts.\"\n\nCharles Yawn, the Chairman of Kali-Extracts and outgoing CEO said, \"Mr. Ferri is a brilliant inventor and pioneer in the exploding field of cannabis extracts.  Mr. Ferri invented his patented cannabis extraction pr...